Cargando…
Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489674/ https://www.ncbi.nlm.nih.gov/pubmed/31114370 http://dx.doi.org/10.2147/CMAR.S199442 |
| _version_ | 1783414865223745536 |
|---|---|
| author | Jayaraj, Rama Kumarasamy, Chellan Sabarimurugan, Shanthi Samiappan, Suja |
| author_facet | Jayaraj, Rama Kumarasamy, Chellan Sabarimurugan, Shanthi Samiappan, Suja |
| author_sort | Jayaraj, Rama |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6489674 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64896742019-05-21 Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy Jayaraj, Rama Kumarasamy, Chellan Sabarimurugan, Shanthi Samiappan, Suja Cancer Manag Res Letter Dove 2019-04-18 /pmc/articles/PMC6489674/ /pubmed/31114370 http://dx.doi.org/10.2147/CMAR.S199442 Text en © 2019 Jayaraj et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Letter Jayaraj, Rama Kumarasamy, Chellan Sabarimurugan, Shanthi Samiappan, Suja Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy |
| title | Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy |
| title_full | Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy |
| title_fullStr | Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy |
| title_full_unstemmed | Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy |
| title_short | Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy |
| title_sort | approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489674/ https://www.ncbi.nlm.nih.gov/pubmed/31114370 http://dx.doi.org/10.2147/CMAR.S199442 |
| work_keys_str_mv | AT jayarajrama approachestointerprettheoutcomesofanetworkmetaanalysisoncomparativeefficacyofdifferenttargetedtherapiesplusfulvestrantforadvancedbreastcancerfollowingprogressiononpriorendocrinetherapy AT kumarasamychellan approachestointerprettheoutcomesofanetworkmetaanalysisoncomparativeefficacyofdifferenttargetedtherapiesplusfulvestrantforadvancedbreastcancerfollowingprogressiononpriorendocrinetherapy AT sabarimuruganshanthi approachestointerprettheoutcomesofanetworkmetaanalysisoncomparativeefficacyofdifferenttargetedtherapiesplusfulvestrantforadvancedbreastcancerfollowingprogressiononpriorendocrinetherapy AT samiappansuja approachestointerprettheoutcomesofanetworkmetaanalysisoncomparativeefficacyofdifferenttargetedtherapiesplusfulvestrantforadvancedbreastcancerfollowingprogressiononpriorendocrinetherapy |